Recent Updates
Recently added Catalysts
ACB Negative Sentiment

Aurora Cannabis Announces Fiscal 2027 Second Quarter Results

Thursday, November 5, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Aurora Cannabis Inc. reported its financial results for Q2 2027, ending September 30, 2026. The company has cancelled its upcoming investor call, which raises concerns about its communication strategy. The cancellation follows a prior announcement made on November 3, 2026, regarding a significant operational change.

Market Sentiment Analysis

CONCERNS & RISKS

  • Aurora cancelled its investor call scheduled for November 12, 2026.
  • The announcement indicates potential communication issues.

Full Press Release Details

EDMONTON, Alberta--(BUSINESS WIRE)--Aurora Cannabis Inc. (the “Company” or “Aurora”) (NASDAQ | TSX: ACB), a leading Canada-based global medical cannabis company, today announced its financial and operational results for the second quarter 2027 ending September 30, 2026. Aurora has cancelled its investor call, originally scheduled for November 12, 2026, at 8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time, due to the Company’s announcement on November 3, 2026, that Aurora has entered into a defin

Frequently Asked Questions

What were Aurora Cannabis's Q2 2027 results?

Aurora Cannabis announced its financial results for Q2 2027, ending September 30, 2026.

Why was the investor call cancelled?

The investor call was cancelled due to a prior announcement made on November 3, 2026.

When was the investor call scheduled?

The investor call was originally scheduled for November 12, 2026.

What does the cancellation imply?

The cancellation raises concerns about the company's communication strategy.

ShareAdd on Google
Tags: ACB Aurora Cannabis financial results Q2 2027 cancellation investor call
Last updated: Nov 5, 2026